Lumexa Imaging (NASDAQ:LMRI) Stock Price Up 6.7% – Here’s Why

Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI) shares were up 6.7% on Monday . The company traded as high as $16.03 and last traded at $15.53. Approximately 239,732 shares were traded during trading, a decline of 62% from the average daily volume of 631,131 shares. The stock had previously closed at $14.55.

Wall Street Analyst Weigh In

Separately, Raymond James Financial upgraded Lumexa Imaging from an “outperform” rating to a “strong-buy” rating and set a $23.00 price target for the company in a report on Monday, February 9th. One analyst has rated the stock with a Strong Buy rating, According to MarketBeat, the stock currently has an average rating of “Strong Buy” and an average price target of $23.00.

Lumexa Imaging Stock Up 3.8%

Institutional Trading of Lumexa Imaging

Several large investors have recently added to or reduced their stakes in the company. Assetmark Inc. acquired a new stake in Lumexa Imaging during the 4th quarter valued at approximately $36,000. Barclays PLC purchased a new position in shares of Lumexa Imaging during the fourth quarter worth $133,000. Sandia Investment Management LP acquired a new position in Lumexa Imaging during the fourth quarter valued at $185,000. Hudson Bay Capital Management LP purchased a new stake in Lumexa Imaging in the fourth quarter valued at $237,000. Finally, Oxford Asset Management LLP purchased a new stake in Lumexa Imaging in the fourth quarter valued at $670,000.

Lumexa Imaging Company Profile

We are one of the largest national providers of diagnostic imaging services(1). Our platform is integrated, scalable and has a proven track record of creating value for our stakeholders. As of September 30, 2025, we and our affiliates operated the second largest(1) outpatient imaging center footprint in the United States. It spans 184 centers(2)across 13 states and includes eight joint venture partnerships with health systems. Our centers are in attractive metropolitan statistical areas (“MSAs”).